SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-075066
Filing Date
2021-06-01
Accepted
2021-06-01 16:34:33
Documents
4
Period of Report
2021-06-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2117624d1_8k.htm 8-K 18178
2 EXHIBIT 10.1 tm2117624d1_ex10-1.htm EX-10.1 295475
3 GRAPHIC tm2117624d1_ex10-1sp1img001.jpg GRAPHIC 9647
4 GRAPHIC tm2117624d1_ex10-1sp3img001.jpg GRAPHIC 8885
  Complete submission text file 0001104659-21-075066.txt   341020
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 21985804
SIC: 3841 Surgical & Medical Instruments & Apparatus